science1 distinct publisher
Newborn genome screening has its first saves. The unsettled part is the bill and the read-out
An Australian study flagged a fatal immune disorder in a baby before symptoms appeared. Dozens of pilots now face harder questions: cost, who interprets variants, and findings nobody can act on.
Publishers:nature.com
Reality
- Evidence58
- Adoption34
- Hype gap+12
- Incentives46
- Confidence55